Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease

NCT01319448 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Malaria
Sickle Cell Crisis

Interventions

DRUG: Proguanil
DRUG: mefloquine plus artesunate
DRUG: Sulfadoxine-pyrimethamine plus amodiaquine

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators

[object Object]
[object Object]
[object Object]